Browse By Region
Browse By Category
Recent News
By Category: Countermeasures
Soligenix Announces Positive One-Year High-Temperature Stability Results with ThermoVax™ Vaccine Heat Stabilization… — PRINCETON, N.J., Jan. 15, 2014 /PRNewswire/ —
- January 16, 2014
- | Filed under Countermeasures and Research
- Share
-
Soligenix Announces Positive One-Year High-Temperature Stability Results with ThermoVax™ Vaccine Heat Stabilization… — PRINCETON, N.J., Jan. 15, 2014 /PRNewswire/ —
- January 16, 2014
- | Filed under Countermeasures and Research
- Share
-
Seven recommendations to enhance preparedness for public health emergencies in the U.S. – Medical News Today
- January 15, 2014
- | Filed under Countermeasures
- Share
-
BioDefense Therapeutics enrolls first patient for favipiravir Phase 3 clinical trials
(Bio PrepWatch) BioDefense Therapeutics said on Tuesday that its first patient for the North American Phase 3 clinical trials for favipiravir, and investigational treatment for flu, has been enrolled. Favipiravir is a new antiviral compound that selectively disrupts the virus’ replication and transcription of RNA and stops the infection cycle.
- January 15, 2014
- | Filed under Countermeasures and Research
- Share
-
Seven recommendations to enhance preparedness for public health emergencies in the U.S.
(Medical News Today) The Sept. 11, 2001 attacks in New York City prompted large increases in government funding to help communities respond and recover after man-made and natural disasters. But, this funding has fallen considerably since the economic crisis in 2008. Furthermore, disaster funding distribution is deeply inefficient: huge cash infusions are disbursed right after Read More »
- January 15, 2014
- | Filed under Countermeasures, Policy & Initiatives, and Public Health
- Share
-
